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Aplasia cutis congenita (ACC) associated with fetus papyraceus is a rare subtype of
aplasia cutis categorized as type V in Frieden's classification. It is characterized by
stellate lesions in a symmetrical distribution over the trunk and proximal extremities.
Conservative treatment is recommended, but there is not a well-defined therapeutic
protocol. We report the case of a type V ACC in a preterm male newborn with
lesions on the trunk and scalp successfully treated with topical 1% silver sulfadiazine
and petrolatum gauze with an excellent evolution. This case associates a severe
affectation of the scalp which represents a rare variant of type V ACC.
K E YWORD S
aplasia cutis congenita, treatment ACC, type V ACC
1 | INTRODUCTION
Aplasia cutis congenita (ACC) is a rare disorder characterized by con-
genital absence of all skin layers in a localized or extensive area.1 ACC
is most frequently found as a solitary lesion on the scalp. However,
face, trunk, buttocks and extremities might be affected.1 It may pre-
sent as an isolated defect, accompanied by other developmental
abnormalities or within a syndrome.2 Frieden classified ACC into nine
groups based on the distribution of the affected area, associated
anomalies, and mode of inheritance.3
1.1 | CASE HISTORY
A 29-week preterm male with a birth weight of 1240 g presented
large stellate atrophic skin defects on his trunk and bilateral proximal
extremities at birth (Figure 1A,B) associated with a horseshoe-shaped
ulceration on the vertex measuring 5 cm × 1 cm (Figure 2A). A trans-
fontanellar ultrasound scan of the newborn did not reveal any alter-
ations in the underlying bone. A fetus papyraceus (FP) was identified
in the placental remnants. The mother was a 32-year-old healthy
primigravid woman who conceived a monocorionic diamniotic twin
pregnancy via artificial insemination. Intrauterine fetal death of one
twin occurred at 14 weeks of gestation without other remarkable
complications during the rest of the pregnancy. The only medication
taken by the mother during pregnancy was paracetamol for
odynophagia. She had not undergone invasive techniques and she
denied any history of illnesses during pregnancy. There was no family
history of ACC, vascular abnormalities, vesiculobullous disease or any
other congenital disorders.
The baby was admitted in neonatal intensive care unit and he
required orotracheal intubation and phototherapy by hyaline mem-
brane disease with higher bilirubin levels. The remaining physical
examination and complementary exams such as electrocardiogram
and abdominal ultrasound were normal. Treatment with 2% topical
mupirocin on the scalp and with adherent hydrocolloid dressings on
the trunk were prescribed with a slight improvement 2 weeks later
(Figures 1C,D and 2B) but due to his skin had eroded and the difficulty
in changing the adherent cures the treatment was changed. After
checking that bilirubin levels, they had been normalized treatment
with topical 1% silver sulfadiazine cream covered by no-adherent pet-
rolatum and hydrocolloid gauze (Urgotul) followed by dry gauze once
daily was started. Lower decreased hemoglobin without increased bili-
rubin levels in capillary blood gas sampling was detected. The patient
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did not develop other complications during the 2 weeks of treatment.
At 8-week-old complete healing of the scalp defect associated with a
large alopecic area was observed (Figure 2C) as well as total epitheli-
zation of the trunk lesions with secondary indurated scars (Figure 1E,
F). A massage to soften the scars was done. Twelve weeks after birth
the patient had an age-appropriate development with complete
healing of the lesions without contractures or mobility limitations
(Figure 1G,H). He developed a large scarring alopecic area surrounding
the vertex (Figure 2D).
2 | DISCUSSION
ACC associated with FP is a rare subtype categorized as type V in
Frieden's classification. It is characterized by stellate lesions in a symmet-
rical distribution over the trunk and proximal extremities (Snyder,
2019).2 The presence of scalp lesions in this subtype is rare and it can be
an indicator of the involvement of internal organs (Wexler 1990;
Pieretti, 2015).4-7 The ACC etiology is unknown; nevertheless, the use of
some toxics (marijuana, cocaine, heroin, and alcohol) during pregnancy
might increase the risk of development. Besides this, it has been associ-
ated with herpes simplex and varicella zoster viral infections and terato-
genic drugs such as misoprostol, valproic acid, angiotensin-converting
enzyme inhibitors, benzodiazepines, and specially metimazol.8
Type V ACC is associated with twin or multiple pregnancies when
one of the twins dies in utero between 12 and 14 weeks of gestation
with resultant FP (Snyder 2019).8 There are different vascular, placen-
tal, or ischemic theories about how this fact could alter the correct
development of the skin (Snyder, 2019).6 The differential diagnosis of
type V ACC includes congenital focal dermal hypoplasias, amniotic
band syndromes, congenital infections, primary bullous diseases, and
birth trauma.8 When a large ACC trunk or low extremity lesion is pre-
sent, there is a high risk of complications such as infections, fluid, and
electrolyte alterations. In addition, there is a risk of local bleeding,
thrombosis, or meningitis in cases of extensive scalp lesions that could
increase the mortality up to 20% to 30%.2,6,8
F IGURE 1 Birth: symmetrical
bilateral translucent atrophic plaques
on the trunk involving the scapular
area and proximal area of the lower
extremities (A, right side; B, left side).
Two-week-old: clinical appearance
after cures with hydrocolloid dressings
every 72 to 96 hours (C, right side; D,
left side). Four-week-old: significant
improvement with scars at month
after finish treatment with daily cures
with 1% topical silver sulfadiazine and
petrolatum dressings for 2 weeks (E,
right side; F, left side). Twelve-week-
old: clinical appearance 12 weeks later
after massaging the scars (G, right
side; H, left side)
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Regarding treatment, there is no protocol. Conservative treatment
is recommended, and surgery is indicated in those patients who do not
improve or those who develop complications (Snyder, 2019; Pieretti,
2015).1,6,9 As sequelae it can produce scar tissue with contractures of
trunk or extremities, in these cases a rigorous massage to soften the tis-
sue is recommended (Snyder, 2019).6 Exclusive conservative therapy
with petrolatum and gauze has been previously used with favorable
results.8-10 However, a recent review of useful treatments in patients
with type V ACC recommends to use a topical antimicrobial with near-
occlusive dressing to reduce the microbial exposure and the fluid loss.6
Morrow et al suggested to use the antimicrobial agent silver sulfadia-
zine twice a day on exposed areas followed by the application of petro-
leum gauze, dry gauze, and a self-adherent wrap, respectively.6
Although, there are patients born in a term with extensive type V ACC
successfully treated with silver sulfadiazine usage without side effects
(Wexler, 1990),6 the baby must always be monitored due to the risk of
potential toxicity and side effects (anemia, renal insufficiency, seizures,
increased bilirubin levels, and high liver enzymes).6,9 Generally, the
dressings used in the cures for long term of these patients with exten-
sive lesions are expensive. We used Urgotul which is a no-adherent
petrolatum and hydrocolloid gauze that was available in our hospital at
themoment. Due to high cost of these type dressings that combine var-
ious components, some authors recommend applied each 2 days
(Kara M, 2018).11 In addition, we think that exclusively vaselinated
gauzes which are cheaper can be used too.
It is important to recognize type V ACC because multiple preg-
nancies in the context of assisted reproductive techniques are increas-
ing.4 Although the affected baby might be at risk of congenital
malformations, type V ACC usually has a good evolution with conser-
vative treatment (Snyder, 2019).4,13
3 | CONCLUSIONS
We present a case of extensive type V ACC associated with FP in a
preterm newborn successfully treated with topical silver sulfadiazine
cream with near-occlusive dressing without complications. Although
there are mostly born term babies that have been treated with good
response and without side effects, the experience in a preterm new-
born is limited. In these babies the bilirubin levels and hemoglobin
values must be strictly monitored. In addition, this case associates a
severe affectation of the scalp and represents a rare variant of type V
ACC with few reported cases in the literature to date (Wexler 1990;
Pieretti, 2015).4,5,13,14
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11. Kara M, Tekgündüz KŞ, Keskin H. A cost-effective treatment model
in dystrophic epidermolysis bullosa with congenital absence of skin.
Dermatol Ther. 2018;31:e12649.
12. Pieretti M, Alcala R, Boggio P, et al. Aplasia cutis congenita associated
with fetus papyraceus. Pediatr Dermatol. 2015;32:858-861.
13. Snyder ML, Ilyas H. Type V aplasia cutis congenita with fetus
papyraceus. JAAD Case Rep. 2019;5:3030–305.
14. Wexler A, Harris M, Lesavoy M. Conservative treatment of cutis
aplasia. Plast Reconstr Surg. 1990;86:1066–1071.
How to cite this article: Silva Díaz E, Molini Menchón MO,
Estébanez Corrales A, et al. Type V aplasia cutis congenita in a
preterm newborn successfully resolved. Dermatologic Therapy.
2020;e13888. https://doi.org/10.1111/dth.13888
4 of 4 SILVA DÍAZ ET AL.
